T&R Biofab Co., Ltd. (246710.KQ)
KRW 4920.0
(-4.65%)
KRW 4920.0
(-4.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 5.19 Billion | 5.75 Billion | 3.23 Billion | 6.8 Billion | 1.28 Billion |
| Cost of Revenue | 4.12 Billion | 4.21 Billion | 3.44 Billion | 4.14 Billion | 698.91 Million |
| Gross Profit | 1.07 Billion | 1.54 Billion | -212.48 Million | 2.65 Billion | 588.21 Million |
| Operating Expenses | 13.8 Billion | 14.26 Billion | 10.03 Billion | 8.16 Billion | 7.3 Billion |
| Selling, General and Administrative Expenses | 2.25 Billion | 2.33 Billion | 2.06 Billion | 1.64 Billion | 4.42 Billion |
| Research and Development Expenses | 4.39 Billion | 3.85 Billion | 3.28 Billion | 2.95 Billion | 2.23 Billion |
| Other Expenses | 7.15 Billion | -603.06 Million | -73.21 Billion | -204.26 Million | - |
| Cost and Expenses | 17.92 Billion | 18.47 Billion | 13.48 Billion | 12.31 Billion | 7.99 Billion |
| Operating Income | -12.72 Billion | -12.89 Billion | -10.25 Billion | -5.5 Billion | -6.85 Billion |
| Interest Expense | - | 1.89 Million | 2.6 Billion | 35.78 Million | 46.01 Million |
| Income Tax Expense | - | -12.51 Million | -72.5 Billion | -147.68 Million | - |
| Earnings before Tax | -13.41 Billion | -10.33 Billion | -70.06 Billion | -5.6 Billion | -6.25 Billion |
| Net Income | -13.41 Billion | -10.33 Billion | -70.06 Billion | -5.6 Billion | -6.25 Billion |
| Earnings Per Share Basic | -633.00 | -496.00 | -1970.00 | -334.50 | -376.50 |
| Earnings Per Share Diluted | -632.85 | -496.00 | -1970.00 | -334.50 | -376.50 |
| Weighted Average Shares Outstanding | 21.19 Million | 20.84 Million | 35.56 Million | 16.75 Million | 16.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.2 Million | 20.84 Million | 35.56 Million | 16.75 Million | 16.6 Million |
| Gross Margin | 0.21 | 0.27 | -0.07 | 0.39 | 0.46 |
| EBIT Margin | -2.17 | -1.90 | -25.05 | -0.64 | -4.70 |
| Profit Margin | -2.58 | -1.80 | -21.66 | -0.82 | -4.86 |
| EBITDA | -11.25 Billion | -10.96 Billion | -65.72 Billion | -4.29 Billion | -6.04 Billion |
| Earnings Before Tax Margin | -2.45 | -2.24 | -3.17 | -0.81 | -5.33 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.36 Billion | 1.18 Billion | 5.19 Billion | 1.43 Billion | 952.91 Million | 1.21 Billion |
| Cost of Revenue | 614.89 Million | 516.26 Million | 4.12 Billion | 1.79 Billion | 625.8 Million | 666.3 Million |
| Gross Profit | 745.56 Million | 671.22 Million | 1.07 Billion | -360.44 Million | 327.11 Million | 551.87 Million |
| Operating Expenses | -4.93 Billion | -4.1 Billion | 13.72 Billion | 3.54 Billion | 3.47 Billion | 3.73 Billion |
| Selling, General and Administrative Expenses | 4.93 Billion | 4.1 Billion | - | 670.07 Million | 566.34 Million | 602.77 Million |
| Research and Development Expenses | 1.68 Billion | 1.45 Billion | - | 1.03 Billion | 1.08 Billion | 1.25 Billion |
| Other Expenses | -9.86 Billion | -8.21 Billion | -1.22 Billion | -1.32 Billion | -7.5 Million | 19.09 Million |
| Cost and Expenses | 614.89 Million | 516.26 Million | 17.85 Billion | 5.34 Billion | 4.1 Billion | 4.4 Billion |
| Operating Income | -4.18 Billion | -3.43 Billion | -12.72 Billion | -3.89 Billion | -3.15 Billion | -3.18 Billion |
| Interest Expense | - | 586.26 Thousand | 3.24 Million | -930.02 Million | 639.6 Million | 137.57 Million |
| Income Tax Expense | - | - | -5.81 Billion | -2.29 Billion | -1.44 Billion | -1.11 Billion |
| Earnings before Tax | -955.77 Million | -7.74 Billion | -13.41 Billion | -271.33 Million | -5.39 Billion | -4.07 Billion |
| Net Income | -955.77 Million | -7.74 Billion | -13.41 Billion | -271.33 Million | -5.39 Billion | -4.07 Billion |
| Earnings Per Share Basic | -44.36 | -365.00 | - | -12.80 | -254.00 | -192.00 |
| Earnings Per Share Diluted | -44.36 | -365.00 | - | -12.80 | -254.00 | -192.00 |
| Weighted Average Shares Outstanding | 21.54 Million | 21.22 Million | 21.2 Million | 21.19 Million | 21.23 Million | 21.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.54 Million | 21.22 Million | 21.2 Million | 21.19 Million | 21.23 Million | 21.21 Million |
| Gross Margin | 0.55 | 0.57 | 0.21 | -0.25 | 0.34 | 0.45 |
| EBIT Margin | 0.55 | 0.57 | - | -3.91 | -4.24 | -3.08 |
| Profit Margin | -0.70 | -6.52 | -2.58 | -0.19 | -5.66 | -3.34 |
| EBITDA | 745.56 Million | 671.22 Million | - | -5.6 Billion | -4.04 Billion | -3.75 Billion |
| Earnings Before Tax Margin | -3.08 | -2.89 | -2.45 | -2.72 | -3.31 | -2.61 |
BC-PA
GFPT
NEM
2086
6682
TES